Abstract
Real-time PCR based on the recN and gyrB genes was developed to detect four Streptococcus bovis/Streptococcus equinus complex (SBEC) subspecies from rectal swab specimens. The overall prevalence was 35.2%: Streptococcus gallolyticus subsp. gallolyticus (11.1%), S. gallolyticus subsp. pasteurianus (13%), Streptococcus infantarius subsp. coli (20.4%), and S. infantarius subsp. infantarius (11.1%). To conclude, these real-time PCR assays provide a reliable molecular method to detect SBEC pathogenic subspecies from rectal swab specimens.
TEXT
In an attempt to define the taxonomy of the Streptococcus bovis/Streptococcus equinus complex (SBEC), researchers have proposed renaming S. bovis biotypes as Streptococcus gallolyticus subsp. gallolyticus (S. bovis biotype I), Streptococcus infantarius subsp. infantarius (S. bovis biotype II/1), Streptococcus infantarius subsp. coli (S. bovis biotype II/1), and Streptococcus gallolyticus subsp. pasteurianus (S. bovis biotype II/2) (1, 2).
S. bovis bacteremia has been found to be related to colorectal cancer (CRC) for more than 30 years (3). Results have suggested that S. gallolyticus sp. is more frequently related to both endocarditis and colonic lesions than S. infantarius sp. (4, 5). Nevertheless, S. infantarius sp. is associated with noncolonic cancer, such as cancer of the pancreas and biliary tract, generally appearing as cholangitis (6).
Authors have claimed that different S. bovis subspecies should be named according to the classification proposed by Schlegel et al. (2) both in clinical practice and in scientific publications, which implies the use of molecular techniques for the subclassification of SBEC (7). Recently, the use of a partial recN gene sequence was explored in order to investigate taxonomy and phylogeny in the genus Streptococcus, and other genes (16S rRNA, groEL, gyrB, rpoB, and sodA) were compared to recN: interspecies and intrasubspecies similarities of recN and gyrB were lower (8).
Therefore, our aim was to use the recN and gyrB genes as targets to develop useful real-time PCR assays to detect S. gallolyticus subsp. gallolyticus, S. gallolyticus subsp. pasteurianus, S. infantarius subsp. coli, and S. infantarius subsp. infantarius from rectal swab specimens in individuals that underwent colonoscopy. The first assay is based on recN, which detects S. gallolyticus subsp. gallolyticus and S. gallolyticus subsp. pasteurianus. The second assay specifically detects S. infantarius subsp. coli and S. infantarius subsp. infantarius based on gyrB.
A total of 19 bacterial strains were evaluated in this study and are listed in Table 1. All five clinical isolates were identified using the technique of matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) by using the Vitek MS system (bioMérieux, Marcy l'Etoile, France) (Table 1). Growth culture strains were resuspended in 500 μl of ultrapurified water and lysed by boiling for 15 min. Cells were pelleted, and the supernatant was separated and stored at −20°C.
TABLE 1.
Group | Species | Straina | qPCR result |
---|---|---|---|
Streptococci | Streptococcus gallolyticus | ATCC 9809 | recN SGG (+) |
Streptococcus gallolyticus subsp. gallolyticus | IMPG RS-51 | recN SGG (+) | |
Streptococcus infantarius subsp. coli | IMPG RS-52 | gyrB SCI (+) | |
Streptococcus infantarius subsp. infantarius | IMPG RS-54 | gyrB SII (+) | |
Streptococcus agalactiae | ATCC 13813 | No amplification | |
Streptococcus salivarius | ATCC 7073 | No amplification | |
Streptococcus mutans | ATCC 25175 | No amplification | |
Streptococcus oralis | ATCC 10557 | No amplification | |
Streptococcus parasanguinis | ATCC 903 | No amplification | |
Streptococcus pyogenes | ATCC 19615 | No amplification | |
Streptococcus pneumoniae | ATCC 33400 | No amplification | |
Other bacteria | Enterococcus faecalis | ATCC 29212 | No amplification |
Enterococcus faecium | ATCC 6569 | No amplification | |
Escherichia coli | ATCC 25922 | No amplification | |
Clinical isolates | Streptococcus gallolyticus subsp. gallolyticus | HMV 317831 | recN SGG (+) |
Streptococcus gallolyticus subsp. pasteurianus | HUSM 2011 | recN SGP (+) | |
Streptococcus gallolyticus subsp. pasteurianus | HMD 6075 | recN SGP (+) | |
Streptococcus gallolyticus subsp. gallolyticus | HMD 6925 | recN SGG (+) | |
Streptococcus gallolyticus subsp. gallolyticus | HMD 305 | recN SGG (+) |
Sources of reference strains: INCQS, National Institute of Quality Health Control—Fiocruz; IMPG, Culture Collection of Paulo de Góes Microbiology Institute—UFRJ.
Rectal swab specimens were collected in accordance with ethical guidelines established by the Ethical Principles for Medical Research Involving Human Subjects (Declaration of Helsinki, 1964) and stored at −80°C. All subjects gave written informed consent, and the study protocol was approved by our local Institutional Ethical Committee.
In a period ranging from June to September 2011, 54 rectal swab specimens were obtained from subjects who underwent colonoscopy at Santa Clara Hospital endoscopy service. Santa Clara Hospital is a general hospital in Porto Alegre, Brazil. Each swab (ESwab; Copan, Brescia, Italy) was suspended in 1 ml of modified liquid Amies medium and stored at −80°C. DNA isolation was performed using the BioPur Mini Spin extraction kit (Biometrix, Curitiba, Brazil).
Partial recN and gyrB nucleotide sequences were analyzed using the BLASTN algorithm to compare the sequences to a database. Afterwards, primers and fluorescent dye-labeled TaqMan MGB probes were designed using the Primer Express v3.0 software program (Applied Biosystems, Foster City, CA). The sequences of primers and probes and product sizes are listed in Table 2. A TaqMan 6-carboxytetramethylrhodamine (TAMRA) real-time PCR assay based on the β-globin gene (Applied Biosystems, Foster City, CA) was used for an internal control.
TABLE 2.
Name | Target | Sequence (5′ → 3′) | Label | Amplicon size (bp) |
---|---|---|---|---|
F-recN SGG/P | recN | 1055-GATTTTCAAGTCCAATTCACCAAAG-1080a | None | 98 |
R-recN SGG/P | recN | 1135-GGTTYGTTGAAATGTAAAATTCAACAG-1107 | None | |
Pf-recN/SGG | recN | 1085-TTCAATCGTGATGGCAA-1102 | FAMd | |
Pv-recN/SGP | recN | 1086-TCAACCGTGATGGAAA-1102 | VIC | |
F-gyrB SIC | gyrB | 194-CGTATTCAGGAACTTGCTTTCTTG-217b | None | 65 |
R-gyrB SIC | gyrB | 258-CCTTCACGTTTGTCAGTGATTGA-236 | None | |
Pf-gyrB/SIC | gyrB | 219-ACCGCGGTTTGCGTAT-234 | FAM | |
F-gyrB SII | gyrB | 86-TTGAAAGTTATTGGTGATACAGATCGT-112c | None | 69 |
R-gyrB SII | gyrB | 154-AAAGATTTCACCGTCTGGAGTGA-132 | None | |
Pv-gyrB/SII | gyrB | 115-CGGTACAACCGTTCAC-130 | VIC |
Sequence numbers based on NCBI accession no. EU917270.1 and EU917274.1 for S. gallolyticus subsp. gallolyticus and S. gallolyticus subsp. pasteurianus recN partial gene sequence.
Sequence numbers based on NCBI accession no. EU003729.1 for S. infantarius subsp. coli gyrB partial gene sequence.
Sequence numbers based on NCBI accession no. EU003767.1 for S. infantarius subsp. infantarius gyrB partial gene sequence.
FAM, 6-carboxyfluorescein.
PCRs for the presence/absence of the recN and gyrB genes were carried out with 4 μl of extracted DNA and 10 μl of master mix, 800 nM (each) primer, and 200 nM probes. DNA was amplified using the StepOnePlus real-time PCR system (Applied Biosystems, Foster City, CA). All reaction conditions included an initial denaturation of 95°C for 10 min, followed by amplifications using 40 cycles of 95°C for 15 s and 60°C for 1 min. The positive specimens were determined as follows: amplification yielded a positive result, and the threshold cycle (CT) deviation for the replicate was not higher than 0.5, with a CT cutoff at 35.
Five clinical isolates and four reference strains (Table 1) were correctly identified using the primer and probe sets designed in these real-time PCR assays. No false-positive amplification reactions were observed when the real-time PCR assays were evaluated against various closely related Streptococcus species, Enterococcus species, and Escherichia coli (Table 2). We ensured adequate primer and probe specificity by alignment of partial sequences retrieved from the GenBank database.
Fifty-four subjects were enrolled (19 males [mean age, 64.6 years; range, 46 to 76] and 35 females [mean age, 57.9; range, 44 to 80]). The overall prevalence of any SBEC subspecies was 35.2% (for males, n = 3; for females, n = 16). For 10 subjects, a single SBEC subspecies was found (2 with S. gallolyticus subsp. gallolyticus, 2 with S. gallolyticus subsp. pasteurianus, and 6 with S. infantarius subsp. coli). Nine subjects harbored multiple species; 7 subjects had two subspecies each. Of the former, two had S. gallolyticus subsp. gallolyticus and S. infantarius subsp. infantarius, two had S. gallolyticus subsp. pasteurianus and S. infantarius subsp. coli, and one had S. gallolyticus subsp. pasteurianus and S. infantarius subsp. infantarius. The two remaining subjects had three subspecies: one with S. gallolyticus subsp. gallolyticus, S. gallolyticus subsp. pasteurianus, and S. infantarius subsp. infantarius and another with S. gallolyticus subsp. gallolyticus, S. infantarius subsp. coli, and S. infantarius subsp. infantarius.
In the present study, two TaqMan-MGB real-time PCR assays were designed to specifically detect subspecies of the SBEC based on sequence analysis of the recN and gyrB genes. To our knowledge, these are the first applicable real-time PCR assays to detect all clinically significant SBEC subspecies. Recently, a multiplex PCR/restriction fragment length polymorphism (RFLP) assay based on 16S rRNA proposed SBEC species identification of isolates from dairy microbial communities. However, this assay was not able to discriminate at the subspecies level (9). Previously, a group developed a PCR/RFLP assay based on groESL for the identification of SBEC subspecies evaluated in reference strains and clinical isolates (10). The combination of excellent sensitivity and specificity, low contamination risk, ease of performance, and speed has made real-time PCR an appealing alternative in the clinical microbiology laboratory (11). These real-time PCR assays could be useful for SBEC subspecies identification in different clinical samples, such as blood, cerebrospinal fluid, and colonic tissues.
We determined that 35.2% of the 54 subjects were colonized with SBEC subspecies, actually S. bovis. This fecal carriage rate is higher than those observed in prior studies (3, 12, 13). Notably, a recently published study (14) showed that the fecal carriage rate of SBEC subspecies was 4.6% among adult subjects with tumorous lesions, nontumorous lesions, and normal colonoscopy results. Those authors used a biomolecular technique and identified SBEC subspecies in the feces of 12 of 259 subjects, with the following distribution: S. lutetiensis (S. infantarius subsp. coli, n = 9; S. gallolyticus subsp. pasteurianus, n = 2; and S. gallolyticus subsp. gallolyticus, n = 1 (14). Our results were in agreement with theirs, with S. infantarius subsp. coli (formerly S. bovis biotype II) being the most commonly identified subspecies (20.4%), and the S. gallolyticus subsp. gallolyticus and S. gallolyticus subsp. pasteurianus fecal carriage rates were similar (11.1% and 13%, respectively). We identified almost half of SBEC-colonized subjects as having concomitant colonization with two or three subspecies. This finding has not been reported previously, possibly due to the fact that in most former studies, fecal culturing was performed for bacterial isolation. We analyzed clinical samples directly after collection of rectal swab specimens; therefore, underestimation of the actual fecal carriage rate was greatly minimized.
The use of molecular techniques for the subclassification of S. bovis/S. equinus complex bacteria is required in order to fully understand the clinical value of SBEC subspecies infections/colonization as early signaling of colonic malignancy or other gastrointestinal diseases (7, 15).
In summary, these real-time PCR assays provide a reliable molecular method to detect SBEC subspecies and quantify S. gallolyticus species from rectal swab specimens. These assays might be a useful tool for screening for and surveillance of colonization by this bacterial complex in individuals subjected to a routine colonoscopy.
ACKNOWLEDGMENTS
We acknowledge the National Institute of Quality Health Control (INCQS/Fiocruz) and Lucia Martins Teixeira (UFRJ) for donation of reference strains.
This work was supported by a grant from the National Counsel of Technological and Scientific Development (CNPq), Brazil.
We have no conflict of interest to declare.
Footnotes
Published ahead of print 3 January 2014
REFERENCES
- 1.Schlegel L, Grimont F, Collins MD, Regnault B, Grimont PA, Bouvet A. 2000. Streptococcus infantarius sp. nov., Streptococcus infantarius subsp. infantarius subsp. nov. and Streptococcus infantarius subsp. coli subsp. nov., isolated from humans and food. Int. J. Syst. Evol. Microbiol. 50:1425–1434. 10.1099/00207713-50-4-1425 [DOI] [PubMed] [Google Scholar]
- 2.Schlegel L, Grimont F, Ageron E, Grimont PA, Bouvet A. 2003. Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov.. Int. J. Syst. Evol. Microbiol. 53:631–645. 10.1099/ijs.0.02361-0 [DOI] [PubMed] [Google Scholar]
- 3.Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, Steigbigel NH. 1977. Association of Streptococcus bovis with carcinoma of the colon. N. Engl. J. Med. 297:800–802. 10.1056/NEJM197710132971503 [DOI] [PubMed] [Google Scholar]
- 4.Garza-Gonzalez E, Rios M, Bosques-Padilla FJ, Fritz F, Ilseung C, Gonzalez GM, Perez-Perez GI. 2012. Immune response against Streptococcus gallolyticus in patients with adenomatous polyps in colon. Int. J. Cancer 131:2294–2299. 10.1002/ijc.27511 [DOI] [PubMed] [Google Scholar]
- 5.Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. 2011. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin. Infect. Dis. 53:870–878. 10.1093/cid/cir609 [DOI] [PubMed] [Google Scholar]
- 6.Corredoira J, Alonso MP, Coira A, Varela J. 2008. Association between Streptococcus infantarius (formerly S. bovis II/1) bacteremia and noncolonic cancer. J. Clin. Microbiol. 46:1570. 10.1128/JCM.00129-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Tjalsma H, Boleij A. 2012. Subtyping of Streptococcus bovis group bacteria is needed to fully understand the clinical value of Streptococcus gallolyticus (S. bovis biotype I) infection as early sign of colonic malignancy. Int. J. Clin. Pract. 66:326. 10.1111/j.1742-1241.2011.02873.x [DOI] [PubMed] [Google Scholar]
- 8.Glazunova OO, Raoult D, Roux V. 2010. Partial recN gene sequencing: a new tool for identification and phylogeny within the genus Streptococcus. Int. J. Syst. Evol. Microbiol. 60:2140–2148. 10.1099/ijs.0.018176-0 [DOI] [PubMed] [Google Scholar]
- 9.Jans C, Lacroix C, Meile L. 2012. A novel multiplex PCR/RFLP assay for the identification of Streptococcus bovis/Streptococcus equinus complex members from dairy microbial communities based on the 16S rRNA gene. FEMS Microbiol. Lett. 326:144–150. 10.1111/j.1574-6968.2011.02443.x [DOI] [PubMed] [Google Scholar]
- 10.Chen HJ, Tsai JC, Chang TC, Hung WC, Tseng SP, Hsueh PR, Teng LJ. 2008. PCR-RFLP assay for species and subspecies differentiation of the Streptococcus bovis group based on groESL sequences. J. Med. Microbiol. 57:432–438. 10.1099/jmm.0.47628-0 [DOI] [PubMed] [Google Scholar]
- 11.Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, Yao JD, Wengenack NL, Rosenblatt JE, Cockerill FR, III, Smith TF. 2006. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin. Microbiol. Rev. 19:165–256. 10.1128/CMR.19.1.165-256.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Burns CA, McCaughey R, Lauter CB. 1985. The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. Am. J. Gastroenterol. 80:42–46 [PubMed] [Google Scholar]
- 13.Dubrow R, Edberg S, Wikfors E, Callan D, Troncale F, Vender R, Brand M, Yapp R. 1991. Fecal carriage of Streptococcus bovis and colorectal adenomas. Gastroenterology 101:721–725 [DOI] [PubMed] [Google Scholar]
- 14.Chirouze C, Patry I, Duval X, Baty V, Tattevin P, Aparicio T, Pagenault M, Carbonnel F, Couetdic G, Hoen B. 2013. Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection. Eur. J. Clin. Microbiol. Infect. Dis. 32:1171–1176. 10.1007/s10096-013-1863-3 [DOI] [PubMed] [Google Scholar]
- 15.Del Campo-Moreno R. 2012. Is it necessary to identify the isolates of the Streptococcus bovis group correctly at subspecies level? Enferm. Infecc. Microbiol. Clin. 30:173–174. 10.1016/j.eimc.2012.01.020 [DOI] [PubMed] [Google Scholar]